THE EIGHTEEN MONTH MORTALITY IS REDUCED WITH A NOVEL IMMUNOSUPPRESSION STRATEGY WHEN AGED LIVERS ARE TRANSPLANTED IN HCV POSITIVE RECIPIENTS